Healthier Capital, a leading health-tech venture capital firm, joins as a co-founder and sole external investor in seed round LA JOLLA, Calif., Jan. 22, 2026 /PRNewswire/ -- Diploid Genomics, Inc.

Microsoft Azure customers worldwide now gain access to XetaBase genomic data technology to take advantage of the scalability, reliability and agility of Azure ...

BIOMAKERS, a precision medicine and oncology intelligence company headquartered in San Francisco, today announced the closing of an additional $8 million. The financing marks a key inflection point as ...

Explore the groundbreaking AI genomics platform, Inference, launched by Variant Bio to enhance drug discovery using genetic ...

SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform.

Transaction combines Sema4’s leading AI- and machine learning-powered integrated genomic and clinical open-architecture data platform, with CM Life Sciences, the leading life science-focused SPAC, led ...

SAN DIEGO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and ...

"CGIE (TM) is being built as future-facing infrastructure rather than a point solution," said Yusuf Henriques, Founder and CEO of IndyGeneUS Bio. "Our objective is to establish the AI×Bio Factory--the ...

WuXi NextCODE closed a $240 million Series B financing round. Sequoia China led the funding round. WuXi NextCODE is a global platform for genomic data. It will use the funds to extend platform ...

The Mystra platform, developed over 10 years, offers biopharma partners proven analytical power to turn months of R&D into minutes, dramatically increasing the availability of quality genetic insights ...